Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP).

Address: Peking University People's Hospital, Beijing 100044, China. Electronic address: [email protected].; Chenzhou No.1 People's Hospital, Chenzhou 423000, China.; Tangshan Gongren Hospital, Tangshan 063000, China.; The Affiliated Hospital of Xuzhou Medical College, Xuzhou 221006, China.; Harrison International Peace Hospital, Hengshui 053000, China.; The Affiliate Hospital of Qingdao University, Qingdao 266003, China.; Chongqing Three Gorges Central Hospital, Chongqing 404000, China.; The Second Hospital of Jilin University, Changchun 130041, China.; Jiangsu Province Hospital, Nanjing 210029, China.; China Meitan General Hospital, Beijing 100028, China.; The Second Affiliate Hospital of Chongqing Medical University, Chongqing 400010, China.; The First Affiliate Hospital of Chongqing Medical University, Chongqing 400016, China.; The Third Hospital of Hebei Medical University, Shijiazhuang 050051, China.; Tianjin Medical University General Hospital, Tianjin 300052, China.; The 306th Hospital of PLA, Beijing 100101, China.; Baogang Hospital of Inner Mongolia, Baotou 014010, China.; Cangzhou's Central Hospital, Cangzhou 031706, China.; Zhongshan Hospital Fudan University, Shanghai 200032, China.; Huaxi Hopsital of Sichuan University, Chengdu 610041, China.; The First Affiliated Hospital of The 4th Military Medical University, Xi'an 710000, China.; Xin Hua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, China.; The Second Xiangya Hospital of Central South University, Changsha 410008, China.; Peking University Shougang Hospital, Beijing 100144, China.; The Central Hospital of Yangpu District of Shanghai, Shanghai 200090, China.; The First Affiliate Hospital of Xiamen University, Xiamen 361003, China.; Zhongnan Hospital of Wuhan University, Wuhan 430071, China.; Shenzhen Chipscreen Biosciences Co., Ltd., Shenzhen 518057, China.; Shanghai 6th People's Hospital, Shanghai 200233, China. Electronic address: [email protected].